Specialty code 183500000X · Yadkinville, NC
NPI
1467740332
Since 2011
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
305 E Lee Ave
Yadkinville, NC, 27055
Phone (336) 679-2661
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.3M
3,115 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Megan F Diffenbaugh prescribed most often to Medicare patients was Xarelto (Rivaroxaban), with 259 prescriptions and refills. In total Megan F Diffenbaugh wrote 3,115 Medicare prescriptions that cost $2.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Xarelto Rivaroxaban | 259 | 752 | 81 | $414K |
| Farxiga Dapagliflozin Propanediol | 175 | 483 | 65 | $269K |
| Jardiance Empagliflozin | 145 | 421 | 54 | $244K |
| Ozempic Semaglutide | 140 | 244 | 57 | $236K |
| Eliquis Apixaban | 131 | 335 | 39 | $194K |
| Rosuvastatin Calcium Generic | 89 | 225 | 29 | $440 |
| Warfarin Sodium Generic | 73 | 162 | 23 | $380 |
| Mounjaro Tirzepatide | 65 | 77 | 21 | $83K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 53 | 119 | 22 | $76K |
| Metformin Hcl Er Metformin Hcl | 50 | 125 | 21 | $439 |
| Rybelsus Semaglutide | 49 | 80 | 19 | $75K |
| Atorvastatin Calcium Generic | 49 | 151 | 19 | $555 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 46 | 89 | 12 | $50K |
| Symbicort Budesonide/Formoterol Fumarate | 46 | 102 | 17 | $22K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 42 | 86 | 15 | $2,648 |
Brand drugs: 1,814 claims; generic drugs: 1,127 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Megan F Diffenbaugh were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.